Factors Influencing Management Modifications Following Fiberoptic Bronchoscopy in Critically Ill ICU Patients

Clinical characteristics of critically ill patients who benefit from bronchoscopy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20230202002

Enrollment

118

Registered

2023-02-02

Start date

2023-02-06

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically ill intensive care unit patients with respiratory system symptoms or abnormalities who underwent bronchoscopy critically ill intensive care unit bronchoscopy

Interventions

Patients who underwent bronchoscope during ICU admission

Screening

Underwent bronchoscope in ICU

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Adult patients (18 years old or over) 2. Admitted to the medical intensive care unit between January 2013 and December 2022 3. Underwent bronchoscope during admission

Exclusion criteria

Exclusion criteria: 1. no pre-bronchoscopic and post-bronchoscopic diagnosis was recorded

Design outcomes

Primary

Measure	Time frame
Changes in management After bronchoscopic results arrived New treatment was introduced, or previous treatment was stopped (Yes or No)	—

Secondary

Measure	Time frame
Changes in diagnosis After bronchoscopic results arrived Changes in pulmonary related diagnosis (Yes or No),Received definite diagnosis After bronchoscopic results arrived Definite diagnosis was diagnosed from bronchoscopic results (Yes or No),Pulmonary infection diagnosis After bronchoscopic results arrived Pulmonary infection was diagnosed from bronchoscopic results (Yes or No),Mortality ICU discharge, 28 days, hospital discharge Mortality (Dead or alive at definite time point),Bronchoscopic adverse events During bronchoscopoy to 24 hours after bronchoscopy Any of these events (Yes or No), desaturation during bronchoscopy, Decrease in PaO2/FiO2 ratio, Bronchospasm, Pneumothorax, Bleeding, Hypertension, Cardiac arrythmia, Hemodynamic instability, Death,Association between respiratory specimen result After pre- and post-bronchoscopic results arrived Diagnosis can be made from Pre-bronchoscopic respiratory specimen (Yes or No), comparing pre-bronchoscopic respiratory specimen result and post-bronchoscopic respiratory specimen result	—

Measure

Time frame

Changes in diagnosis After bronchoscopic results arrived Changes in pulmonary related diagnosis (Yes or No),Received definite diagnosis After bronchoscopic results arrived Definite diagnosis was diagnosed from bronchoscopic results (Yes or No),Pulmonary infection diagnosis After bronchoscopic results arrived Pulmonary infection was diagnosed from bronchoscopic results (Yes or No),Mortality ICU discharge, 28 days, hospital discharge Mortality (Dead or alive at definite time point),Bronchoscopic adverse events During bronchoscopoy to 24 hours after bronchoscopy Any of these events (Yes or No), desaturation during bronchoscopy, Decrease in PaO2/FiO2 ratio, Bronchospasm, Pneumothorax, Bleeding, Hypertension, Cardiac arrythmia, Hemodynamic instability, Death,Association between respiratory specimen result After pre- and post-bronchoscopic results arrived Diagnosis can be made from Pre-bronchoscopic respiratory specimen (Yes or No), comparing pre-bronchoscopic respiratory specimen result and post-bronchoscopic respiratory specimen result

—

Countries

Thailand

Contacts

Public ContactChailat Maluangnon

Faculty of Medicine Siriraj hospital

chailat.mal@mahidol.ac.th024198597

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026